Regulations.gov document
Enclosure 1 Labeling of the Proposed Product - Cefdinir Chewable Tablets 187.5 mg, 250 mg…
Supporting & Related Material · FDA-2006-P-0013 · posted Aug 14, 2008
Key facts
| Document ID | FDA-2006-P-0013-0004 |
|---|---|
| Title | Enclosure 1 Labeling of the Proposed Product - Cefdinir Chewable Tablets 187.5 mg, 250 mg, and 300 mg re: Citizen Petition from Lupin Pharmaceuticals, Inc. |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2006-P-0013 |
| Posted | Aug 14, 2008 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: